Brad Cleveland, the retired Proto Labs CEO who died of brain cancer in September at 56, gave money a good name.
A computer scientist by training with exceptional organizational skills, Cleveland invested $600,000 in borrowed money when he joined fledgling Proto Labs in 2001.
He made tens of millions after it went public in 2012 and headed toward a market value of $2 billion, employing hundreds of Minnesotans at several plants — thanks to a global market for its internet-enabled technology that allows rapid prototyping of parts for manufacturers.
Cleveland and his wife, Pat, donated millions to the Mayo Clinic, where he was treated for years, to charities and a few promising businesses.
One of them, Activated Research Co. (ARC), is led by Andrew Jones, who was a chemical engineering student Cleveland mentored a decade ago at the University of Minnesota.
ARC has gotten traction. Cleveland and Jones wanted to make a difference with research that Jones commenced as a doctoral student at the University of California, Berkeley.
The Clevelands invested $750,000 to capitalize ARC in a Cleveland-owned building in Eden Prairie.
The company's first product, the Polyarc system, is an add-on component to a gas chromatograph that helps researchers in drugs, biofuels, biotechnology and other industries analyze precisely and with improved speed and accuracy the exact composition of chemicals.